Canadian household prescription drug expenditures are studied using different years of the Statistics Canada Family Expenditure Survey. Master files are used, expanding the number of available years and permitting provincial rather than regional identifiers. Nonparametric Engel curves are...

This paper develops a model of the war against illegal drugs in both producer and consumer countries. The paper studies the trade-off faced by the government of the drug consumer country between prevention policies (aimed at reducing the demand for drugs) and enforcement policies (aimed at...

Using state-level data for the period 1990 through 2007, we estimate the effect of legalizing medical marijuana on suicide rates. Our results suggest that the passage of a medical marijuana law is associated with an almost 5 percent reduction in the total suicide rate, an 11 percent reduction in...

The article is based on qualitative research carried out by the authors at the seven Psychosocial Care Centers for Alcohol and other Drugs (CAPS AD) in the Federal District, in order to observe the implementation of the Ministry of Health Policy for Comprehensive Care for Users of Alcohol and...

Alex Brill and Scott Ganz estimate per-capita state-level and county-level non-mortality and total economic burdens of the opioid crisis in 2015.

The rules underlying the assessment of quality of generic drugs, and their bioequivalence to brand name products, have not changed significantly since the passage of the Hatch-Waxman Act in 1984. Yet the products on the market are significantly more complicated today, which may imply that two...